Profil
Eric A. Gulve is currently the Chairman of Drosmed LLC, President of BioGenerator, and Executive Vice President of BioSTL.
He previously served as Director of Neurolutions, Inc. and Cardialen, Inc. and as an Investor Director of Pulse Therapeutics, Inc. He also served as President of BioGenerator (Venture Capital).
Dr. Gulve holds a doctorate degree from Harvard University and an undergraduate degree from Occidental College.
Postes actifs de Eric Gulve
| Sociétés | Poste | Début |
|---|---|---|
Drosmed LLC
Drosmed LLC Drugstore ChainsRetail Trade Provides and develops drugs | Président | 09/06/2011 |
BioSTL
BioSTL Financial ConglomeratesFinance Engages in investing, collaborating and advising in new business in biotechnology, life sciences and medical industries | President | 01/02/2014 |
BioGenerator
BioGenerator Miscellaneous Commercial ServicesCommercial Services Facilitates formation of Science companies | President | 21/12/2022 |
Anciens postes connus de Eric Gulve
| Sociétés | Poste | Fin |
|---|---|---|
Neurolutions, Inc.
Neurolutions, Inc. Packaged SoftwareTechnology Services Operates as a medical technology company dedicated to transforming the lives of patients suffering from neurological condition | Directeur/Membre du Conseil | 02/12/2019 |
Pulse Therapeutics, Inc.
Pulse Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides medical devices to destroy blood clots | Directeur/Membre du Conseil | 16/01/2019 |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Develops low-energy defibrillation and cardio version therapy designed to treat atrial fibrillation and ventricular tachycardia | Directeur/Membre du Conseil | 01/07/2018 |
| GALERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator invests in companies located in the United States. The firm targets companies operating in the fields of healthcare and agriculture sectors. It provides financing for early stage capital requirements. | President | - |
Formation de Eric Gulve
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Neurolutions, Inc.
Neurolutions, Inc. Packaged SoftwareTechnology Services Operates as a medical technology company dedicated to transforming the lives of patients suffering from neurological condition | Technology Services |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Develops low-energy defibrillation and cardio version therapy designed to treat atrial fibrillation and ventricular tachycardia | Health Technology |
Galera Therapeutics, Inc.
Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Occidental College
Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator invests in companies located in the United States. The firm targets companies operating in the fields of healthcare and agriculture sectors. It provides financing for early stage capital requirements. | Finance |
Pulse Therapeutics, Inc.
Pulse Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides medical devices to destroy blood clots | Electronic Technology |
Drosmed LLC
Drosmed LLC Drugstore ChainsRetail Trade Provides and develops drugs | Retail Trade |
BioGenerator
BioGenerator Miscellaneous Commercial ServicesCommercial Services Facilitates formation of Science companies | Commercial Services |
BioSTL
BioSTL Financial ConglomeratesFinance Engages in investing, collaborating and advising in new business in biotechnology, life sciences and medical industries | Finance |
















